Brazil accounts for nearly 90% of the leprosy cases in the Americas

Read full text
Authors: Ana Flávia Sobral de Medeiros, A. L. F. BATISTA, Sidnei Miyoshi Sakamoto, Diogo Manuel Lopes de Paiva Cavalcanti, Renata Ferreira Magalhães
Cited by: 0

Abstract

BACKGROUND: Leprosy is endemic to Brazil. The Coronavirus disease 2019 (COVID-19) pandemic may have affected diagnosis and treatment. METHODS: Study in Mossoró-RN (2018-2023) analyzing epidemiological data, treatment abandonment, and COVID-19 co-infection. RESULTS: The average weekly number of cases declined during the post-pandemic period. The dropout rate was higher during the acute phase. Male sex was associated with dropout (odds ratio [OR], 6.32; p = 0.013). Of the 57 patients tested for COVID-19, 21 tested positive, with no clinical aggravation. CONCLUSIONS: The pandemic has affected leprosy control. Local strategies helped reduce the impact, and co-infection did not worsen the disease.

Fields of Study & Subjects

Leprosy Research and Treatment Research on Leishmaniasis Studies Syphilis Diagnosis and Treatment

Publication details

Journal / source
Revista da Sociedade Brasileira de Medicina Tropical
Volume
59
Pages
e0276–e0276
Publication date
1 January 2026
Language
EN